Quazi T. H. Shubhra
Academic & Professional Appointments
Current & Incoming Appointments
Incoming Research Group Leader (Full-Time): Starting September 2026
March 2023 – Present (until 2029): Assistant Professor (Part-Time): Institute of Chemistry, University of Silesia, Poland
Past Appointments
April 2023 – March 2026: Distinguished Professor: Renmin Hospital of Wuhan University, China
2021 – 2023: R&D Manager, Wuhan Senstar Biotech, China
2019 – 2021: Postdoctoral Researcher, Guangzhou Medical University, China
2017 – 2018: Postdoctoral Scholar, Okinawa Institute of Science and Technology (OIST), Japan
2015 – 2017: JSPS Postdoctoral Fellow, National Institute of Advanced Industrial Science and Technology (AIST), Japan
2011 – 2014: Chemist: University of Pannonia, Hungary
Contact
tanminul-haque-shubra.quazi@us.edu.pl
shubhro.du@gmail.com
GoogleScholar ResearchGate ORCID LinkedIn X
Editorial Board Membership
Associate Editor: Journal of Translational Medicine (IF 9.7); BJC Reports (IF 3.8)
Youth Editor: Research (IF 12.9); Nano Materials Science (IF 20.5)
Editorial board member: Communications Medicine (IF 7.4), Advanced Biotechnology (IF 8.8), International Journal of Nanomedicine (IF 8.7), Scientific Reports (IF 4.9), Discover Oncology (IF 2.8), Discover Nano (IF 6.7), Med Research, Innovation Drug Discovery, Med Research, Innovation Drug Discovery, Medicine Discovery, iMetaMed+ more
Selected Honors & Fellowships
- Stanford/Elsevier Top 2% Scientist (2024, 2025)
- Rector’s Award for Outstanding Research Achievements, University of Silesia (2024, 2025)
- Marie Curie PhD Fellowship, European Commission (2011–2014)
- JSPS Postdoctoral Fellowship, Japan (2015–2017)
- Lindau Nobel Laureate Meeting Germany (2015) & HOPE Meeting with Nobel Laureates Japan (2016)
Selected articles
*Quazi T. H. Shubhra, Xiaojun Cai. Mixing Metals with MXenes; Nature Reviews Chemistry, 2024, 8, 877–878. (IF 50.3) LINK
Qiang Cai*, Xiaojun Cai, Quazi T. H. Shubhra*. Mitochondrial transfer drives immune evasion in tumor microenvironment. Trends in Cancer, 2025, 11(5), 424-426. (IF 21.6) Link
*Kai Guo#, Yixuan Liu#, Lirui Tang, *Quazi T. H. Shubhra. Homotypic Biomimetic Coating Synergizes Chemo-Photothermal Combination Therapy to Treat Breast Cancer Overcoming Drug Resistance; Chemical Engineering Journal, 2022, 428, 131120. (IF 12.5) LINK
Hongyang Lu, Qiang Zhou, Jiayu Li, Shengming Xu, Li Yu, Yinci Zhu, He Zhang, Chengge Shi, Tianci Zuo, Mengzhu Xu, Mingli Su, Yanmei Zhang, Rongdang Hu, *Quazi T. H. Shubhra, *Hui Deng, *Xiaowen Hu, *Xiaojun Cai. CO-Releasing Polyoxometalates Nanozyme with Gut Mucosal Immunity and Microbiota Homeostasis Remodeling Effects for Restoring Intestinal Barrier Integrity. Advanced Science, 2025, 12(17), 2500116. (IF 14.1) LINK
*#Qiang Cai, #Yihao Tian, *Quazi T. H. Shubhra. Targeting Metabolic Circuitry to Supercharge CD8+ T Cell Antitumor Responses; Cell Metabolism, 2024, 36(5), 884-886. (IF 37.0) Link
*Quazi T. H. Shubhra, Qiang Cai. Advancing Rectal Cancer Therapy: mFOLFIRINOX Reduces Metastasis and Improves Survival Outcomes; Annals of Oncology; 2024, 35(11), 1062-1063. (IF 80.4) LINK
*#Qiang Cai, #Yihao Tian, *Quazi T. H. Shubhra. Pre-Activated Macrophage Membrane-Encased Aggregation-induced Emission Featuring Nanoparticles: A Novel Possibility for Tuberculosis Treatment; Signal Transduction and Targeted Therapy 2024, 9, 164, DOI: 10.1038/s41392-024-01855-8. (Impact Factor 81.2) LINK
